The Latest Cardiac and Vascular News
REDWOOD CITY, Calif.–(BUSINESS WIRE)–InterVene, Inc., a privately held medical device company pioneering interventional devices for venous occlusions, today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Recana® Thrombectomy Catheter System for treating venous in-stent restenosis and native vessel obstructions. Recana is a fully […]
SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ — Solaris Endovascular, Inc., a U.S.-based, growth-stage medical device company pioneering next-generation endovascular stent-graft technology, today shared interim results from the DEScover Clinical Trial at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 conference. The data mark a major advance in the treatment […]
Novel platform combining imaging, AI, and robotics aims to enhance IV placement success rates and patient experience Novel platform combining imaging, AI, and robotics aims to enhance IV placement success rates and patient experience
Vertex Pulmonary Embolectomy System with Transforming Fixation (TFX) Technology Demonstrates Excellent Safety, Performance and Cardiac Recovery MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology company developing a new class of endovascular interventions using its proprietary Transforming Fixation (TFX) technology, today announced positive results from the SPIRARE I first-in-human (FIH) […]
ompany to host symposia highlighting results of the POWER PAD II U.S. IDE trial WALTHAM, Mass.–(BUSINESS WIRE)–Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease, announced its schedule of events for the upcoming Transcatheter Cardiovascular Therapeutics (TCT) and Vascular InterVentional Advances […]
The wireless and implantable sensor is robust enough to withstand dynamic process of being crimped into a catheter and deployed inside the vessel SEOUL, South Korea, Oct. 22, 2025 /PRNewswire/ — Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal…
With this labeling approval, Medtronic continues to lead the way in advancing aortic care with clinical evidence for the treatment of ruptured abdominal aortic aneurysms (rAAA). Medtronic plc, a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) labeling approval1 for the Medtronic Endurant™ […]
SAN JOSE, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., the innovator of the only commercially available volume-expanding shape memory polymer for endovascular embolization applications, announced today that it has received approvals from both Singapore’s Health Science Authority (HSA) and Malaysia’s Medical Device Authority (MDA) to market the IMPEDE Embolization Plug, the IMPEDE-FX […]
Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of its Investigational Device Exemption. ST. LOUIS, Oct. 9, 2025 /PRNewswire/ — Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to…
BOERNE, Texas, Oct. 8, 2025 /PRNewswire/ — Building once again on their first mover position as a leader in endovascular hemorrhage control and resuscitation, Prytime Medical Devices, Inc. (Prytime) this week announced a new FDA 510(k) clearance for their flagship pREBOA-PRO™ Catheter….
